UCB S.A. UNSP.ADR 1/2 - Asset Resilience Ratio

Latest as of June 2026: 2.05%

UCB S.A. UNSP.ADR 1/2 (UNC0) has an Asset Resilience Ratio of 2.05% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See UCB S.A. UNSP.ADR 1/2 (UNC0) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€422.00 Million

≈ $493.36 Million USD Cash + Short-term Investments

Total Assets

€20.63 Billion

≈ $24.12 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how UCB S.A. UNSP.ADR 1/2's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see UCB S.A. UNSP.ADR 1/2 total assets.

Liquid Assets Composition Over Time

This chart breaks down UCB S.A. UNSP.ADR 1/2's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read UNC0 liabilities breakdown for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€422.00 Million	2.05%
Total Liquid Assets	€422.00 Million	2.05%

Asset Resilience Insights

Limited Liquidity: UCB S.A. UNSP.ADR 1/2 maintains only 2.05% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

UCB S.A. UNSP.ADR 1/2 Industry Peers by Asset Resilience Ratio

Compare UCB S.A. UNSP.ADR 1/2's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for UCB S.A. UNSP.ADR 1/2 (2021–2025)

The table below shows the annual Asset Resilience Ratio data for UCB S.A. UNSP.ADR 1/2.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.08%	€196.00 Million ≈ $229.14 Million	€18.16 Billion ≈ $21.23 Billion	+0.02pp
2024-12-31	1.06%	€184.00 Million ≈ $215.12 Million	€17.35 Billion ≈ $20.28 Billion	-0.19pp
2023-12-31	1.25%	€195.00 Million ≈ $227.98 Million	€15.54 Billion ≈ $18.17 Billion	-0.28pp
2022-12-31	1.53%	€243.00 Million ≈ $284.09 Million	€15.87 Billion ≈ $18.55 Billion	+0.04pp
2021-12-31	1.49%	€212.00 Million ≈ $247.85 Million	€14.21 Billion ≈ $16.61 Billion	--

pp = percentage points

About UCB S.A. UNSP.ADR 1/2

F:UNC0 Germany Biotechnology

Market Cap

$53.31 Billion

€45.60 Billion EUR

Market Cap Rank

#611 Global

#124 in Germany

Share Price

€120.00

Change (1 day)

-2.44%

52-Week Range

€71.50 - €142.00

All Time High

€142.00